About Glioblastoma (“GBM”)

October 25, 2016 | Video

View More Videos

  • VBI-1901: SNO Phase 2a Data & Clinical Update

    Jeff Baxter and David E. Anderson, Ph.D., discuss updated Phase 2a (Part B) data of VBI-1901 in recurrent GBM patients, as presented at SNO 2020.

    Watch NowArrow
  • Sci-B-Vac® Late-Breaker Oral Presentation at EASL 2020

    Adam Finn, M.D., Ph.D., discusses Data from the Sci-B-Vac® Phase 3 program at EASL.

    Watch NowArrow
  • Preclinical Coronavirus Program Data Webcast

    VBI discusses preclinical coronavirus program data and selection of clinical candidates with potential as one-dose vaccines.

    Watch NowArrow
  • VBI-1901: AACR Data and Clinical Update

  • VBI-1901: AACR 2020 Webcast

    David E. Anderson, Ph.D., discusses updated Part B data from the VBI’s ongoing Phase 1/2a study of VBI-1901.

    Watch NowArrow
  • First- and Second-Generation Hepatitis B Vaccines

  • VBI-1901 Therapeutic Cancer Vaccine Design

  • Preclinical Studies in Glioblastoma (“GBM”)

    In preclinical studies, VBI demonstrated that its vaccine candidate stimulated immune responses critical to efficacious anti-tumor immunity.

    Watch NowArrow
  • Next Steps in the Development of Sci-B-Vac™

    Sci-B-Vac™ is a licensed third-generation hepatitis B vaccine that has demonstrated safety and efficacy in over 300,000 patients. Sci-B-Vac™ is currently approved for use in Israel and in 14 other countries.

    Watch NowArrow
  • About Medulloblastoma (“MB”)

    Medulloblastoma is the most common malignant primary brain tumor in children.

    Watch NowArrow
  • LPV™ Thermostability Platform

  • About Hepatitis B

    Hepatitis B is a disease of the liver caused by the hepatitis B virus (“HBV”) characterized by inflammation, injury, and even cell death.

    Watch NowArrow
  • Cytomegalovirus (“CMV”) Vaccine Candidate

  • Enveloped Virus-Like Particle (“eVLP”) Platform Technology

  • eVLP Platform Technology

    VBI’s eVLP Platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines.

    Watch NowArrow

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up NowArrow
Go top